🇺🇸 FDA
Patent

US 8435979

Use of imipramine blue and analogs thereof in treating cancers

granted A61KA61K31/136A61K31/14

Quick answer

US patent 8435979 (Use of imipramine blue and analogs thereof in treating cancers) held by The United States of America as Represented by the Dept. of Veterans Affairs expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Dept. of Veterans Affairs
Grant date
Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/136, A61K31/14, A61K31/353, A61K31/404